BioAdaptives, Inc. Commences Development of a New Supplement for Women’s Health
October 05, 2023 08:00 ET
|
BioAdaptives, Inc.
PluriPain®-PMS is an Advanced Derivative of the Company’s Popular Supplement, PluriPain® LAS VEGAS, NV, Oct. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTC: BDPT), a...
BioAdaptives, Inc. Launching Next Generation Products for Natural Health Practitioners
July 14, 2022 07:00 ET
|
BioAdaptives, Inc.
Enhanced products For Use by Holistic Healthcare Practitioners – $21b US Market For Alternative Medicine Goods and Services LAS VEGAS, NV, July 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire –...
BioAdaptives, Inc. Brings Top Revolutionary Formulas Together in Wellness Introductory Offer
June 29, 2022 07:00 ET
|
BioAdaptives, Inc.
Responding to Consumers, Management Offers Cost-Effective Combination With Enhanced Synergistic Benefits LAS VEGAS, NV , June 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc....